Saturday 25 December 2010

Midazolam Combino Pharm




Midazolam Combino Pharm may be available in the countries listed below.


Ingredient matches for Midazolam Combino Pharm



Midazolam

Midazolam hydrochloride (a derivative of Midazolam) is reported as an ingredient of Midazolam Combino Pharm in the following countries:


  • Spain

International Drug Name Search

Wednesday 22 December 2010

Calma




Calma may be available in the countries listed below.


Ingredient matches for Calma



Calcium Carbonate

Calcium Carbonate is reported as an ingredient of Calma in the following countries:


  • Italy

Dimenhydrinate

Dimenhydrinate is reported as an ingredient of Calma in the following countries:


  • Sweden

International Drug Name Search

Tuesday 21 December 2010

Rochagan




Rochagan may be available in the countries listed below.


Ingredient matches for Rochagan



Benznidazole

Benznidazole is reported as an ingredient of Rochagan in the following countries:


  • Brazil

International Drug Name Search

Sunday 19 December 2010

Instana Pediatrico




Instana Pediatrico may be available in the countries listed below.


Ingredient matches for Instana Pediatrico



Cefpodoxime

Cefpodoxime proxetil (a derivative of Cefpodoxime) is reported as an ingredient of Instana Pediatrico in the following countries:


  • Spain

International Drug Name Search

Wednesday 15 December 2010

Aminofilina Biocrom




Aminofilina Biocrom may be available in the countries listed below.


Ingredient matches for Aminofilina Biocrom



Aminophylline

Aminophylline is reported as an ingredient of Aminofilina Biocrom in the following countries:


  • Argentina

International Drug Name Search

Friday 3 December 2010

Bilutamid




Bilutamid may be available in the countries listed below.


Ingredient matches for Bilutamid



Bicalutamide

Bicalutamide is reported as an ingredient of Bilutamid in the following countries:


  • Hungary

International Drug Name Search

Tuesday 30 November 2010

Methycobide




Methycobide may be available in the countries listed below.


Ingredient matches for Methycobide



Mecobalamin

Mecobalamin is reported as an ingredient of Methycobide in the following countries:


  • Japan

International Drug Name Search

Suspensio Zinci Oxydati




Suspensio Zinci Oxydati may be available in the countries listed below.


Ingredient matches for Suspensio Zinci Oxydati



Ethambutol

Ethambutol dihydrochloride (a derivative of Ethambutol) is reported as an ingredient of Suspensio Zinci Oxydati in the following countries:


  • Slovakia

International Drug Name Search

Friday 26 November 2010

Pressin




Pressin may be available in the countries listed below.


Ingredient matches for Pressin



Prazosin

Prazosin hydrochloride (a derivative of Prazosin) is reported as an ingredient of Pressin in the following countries:


  • Australia

International Drug Name Search

Monday 15 November 2010

Daptomycin


Pronunciation: DAP-toe-MYE-sin
Generic Name: Daptomycin
Brand Name: Cubicin


Daptomycin is used for:

Treating serious infections caused by certain bacteria. It may also be used for other conditions as determined by your doctor.


Daptomycin is an antibiotic. It works by killing sensitive bacteria.


Do NOT use Daptomycin if:


  • you are allergic to any ingredient in Daptomycin

Contact your doctor or health care provider right away if any of these apply to you.



Before using Daptomycin:


Some medical conditions may interact with Daptomycin. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have muscle problems, nerve problems, liver problems, kidney problems, or bowel problems caused by antibiotic use

Some MEDICINES MAY INTERACT with Daptomycin. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • HMG-CoA reductase inhibitors (eg, atorvastatin) or warfarin because the risk of their side effects may be increased by Daptomycin

  • Tobramycin because its effectiveness may be decreased by Daptomycin

This may not be a complete list of all interactions that may occur. Ask your health care provider if Daptomycin may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Daptomycin:


Use Daptomycin as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Daptomycin is usually given as an injection at your doctor's office, hospital, or clinic. If you will be using Daptomycin at home, a health care provider will teach you how to use it. Be sure you understand how to use Daptomycin. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.

  • Do not use Daptomycin if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.

  • To clear up your infection completely, use Daptomycin for the full course of treatment. Keep using it even if you feel better in a few days.

  • Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.

  • If you miss a dose of Daptomycin, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Daptomycin.



Important safety information:


  • Daptomycin may cause dizziness. This effect may be worse if you take it with alcohol or certain medicines. Use Daptomycin with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Daptomycin only works against bacteria; it does not treat viral infections (eg, the common cold).

  • Mild diarrhea is common with antibiotic use. However, a more serious form of diarrhea (pseudomembranous colitis) may rarely occur. This may develop while you use the antibiotic or within several months after you stop using it. Contact your doctor right away if stomach pain or cramps, severe diarrhea, or bloody stools occur. Do not treat diarrhea without first checking with your doctor.

  • Be sure to use Daptomycin for the full course of treatment. If you do not, the medicine may not clear up your infection completely. The bacteria could also become less sensitive to this or other medicines. This could make the infection harder to treat in the future.

  • Long-term or repeated use of Daptomycin may cause a second infection. Tell your doctor if signs of a second infection occur. Your medicine may need to be changed to treat this.

  • Eosinophilic pneumonia, a rare but serious condition, has been reported with the use of Daptomycin. Contact your doctor right away if you experience new or worsening fever, cough, shortness of breath, or trouble breathing. Discuss any questions or concerns with your doctor.

  • Lab tests, including white blood cell counts and creatine phosphokinase, may be performed while you use Daptomycin. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Daptomycin with caution in the ELDERLY; they may be more sensitive to its effects.

  • Daptomycin should be used with extreme caution in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Daptomycin while you are pregnant. It is not known if Daptomycin is found in breast milk. If you are or will be breast-feeding while you use Daptomycin, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Daptomycin:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; diarrhea; dizziness; headache; nausea; pain, swelling, or redness at the injection site; sore throat; sweating; trouble sleeping; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; chest pain; tightness in the chest; swelling of the mouth, face, lips, or tongue); bloody or watery stools; change in the amount of urine produced; fever; muscle pain or weakness; numbness or tingling; severe or persistent diarrhea; stomach cramps/pain; swelling (eg, of the hands, ankles, feet); symptoms of eosinophilic pneumonia (eg, new or worsening fever, cough, shortness of breath, or trouble breathing); unusual tiredness or weakness.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Daptomycin side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Daptomycin:

Daptomycin is usually handled and stored by a health care provider. If you are using Daptomycin at home, store Daptomycin as directed by your pharmacist or health care provider. Keep Daptomycin out of the reach of children and away from pets.


General information:


  • If you have any questions about Daptomycin, please talk with your doctor, pharmacist, or other health care provider.

  • Daptomycin is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Daptomycin. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Daptomycin resources


  • Daptomycin Side Effects (in more detail)
  • Daptomycin Use in Pregnancy & Breastfeeding
  • Daptomycin Drug Interactions
  • Daptomycin Support Group
  • 0 Reviews for Daptomycin - Add your own review/rating


  • Daptomycin Professional Patient Advice (Wolters Kluwer)

  • Daptomycin Monograph (AHFS DI)

  • Cubicin Consumer Overview

  • Cubicin Prescribing Information (FDA)

  • daptomycin Intravenous Advanced Consumer (Micromedex) - Includes Dosage Information



Compare Daptomycin with other medications


  • Bacteremia
  • Endocarditis
  • Methicillin-Resistant Staphylococcus Aureus Infection
  • Skin and Structure Infection
  • Skin Infection

Sunday 14 November 2010

Chanamast




Chanamast may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Chanamast



Cloxacillin

Cloxacillin benzathine (a derivative of Cloxacillin) is reported as an ingredient of Chanamast in the following countries:


  • Ireland

  • United Kingdom

International Drug Name Search

Friday 12 November 2010

Adco-Zolpidem




Adco-Zolpidem may be available in the countries listed below.


Ingredient matches for Adco-Zolpidem



Zolpidem

Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Adco-Zolpidem in the following countries:


  • South Africa

International Drug Name Search

Monday 8 November 2010

Dexan




Dexan may be available in the countries listed below.


Ingredient matches for Dexan



Dexamethasone

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Dexan in the following countries:


  • Bangladesh

Pseudoephedrine

Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Dexan in the following countries:


  • Chile

International Drug Name Search

Donamet




Donamet may be available in the countries listed below.


Ingredient matches for Donamet



Ademetionine

Ademetionine is reported as an ingredient of Donamet in the following countries:


  • Italy

International Drug Name Search

Monday 1 November 2010

Neobacin




Neobacin may be available in the countries listed below.


Ingredient matches for Neobacin



Bacitracin

Bacitracin zinc salt (a derivative of Bacitracin) is reported as an ingredient of Neobacin in the following countries:


  • Oman

Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Neobacin in the following countries:


  • Oman

International Drug Name Search

Tuesday 26 October 2010

Bi-Profénid




Bi-Profénid may be available in the countries listed below.


Ingredient matches for Bi-Profénid



Ketoprofen

Ketoprofen is reported as an ingredient of Bi-Profénid in the following countries:


  • Benin

  • Burkina Faso

  • Cameroon

  • Central African Republic

  • Chad

  • Congo

  • Cote D'ivoire

  • France

  • Gabon

  • Guinea

  • Madagascar

  • Mali

  • Mauritania

  • Mauritius

  • Niger

  • Senegal

  • Togo

  • Zaire

International Drug Name Search

Saturday 23 October 2010

Trimethadione




In the US, Trimethadione (trimethadione systemic) is a member of the drug class oxazolidinedione anticonvulsants and is used to treat Epilepsy, Seizure Prevention and Seizures.

US matches:

  • Trimethadione

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N03AC02

CAS registry number (Chemical Abstracts Service)

0000127-48-0

Chemical Formula

C6-H9-N-O3

Molecular Weight

143

Therapeutic Category

Antiepileptic agent

Chemical Name

2,4-Oxazolidinedione, 3,5,5-trimethyl-

Foreign Names

  • Trimethadionum (Latin)
  • Trimethadion (German)
  • Triméthadione (French)
  • Trimetadiona (Spanish)

Generic Names

  • Trimethadione (OS: BAN, JAN)
  • Triméthadione (OS: DCF)
  • Troxidone (OS: BAN)
  • Trimethinum (IS)
  • Trimethadion (PH: Ph. Eur. 6)
  • Trimethadione (PH: BP 2010, JP XIV, Ph. Int. 4, USP 23, Ph. Eur. 6)
  • Trimethadionum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

  • Mino Aleviatin
    Dainippon Sumitomo, Japan


  • Tridione
    Abbott, United States

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Muxenon




Muxenon may be available in the countries listed below.


Ingredient matches for Muxenon



Acetylcysteine

Acetylcysteine is reported as an ingredient of Muxenon in the following countries:


  • Vietnam

International Drug Name Search

Friday 22 October 2010

Enalamerck




Enalamerck may be available in the countries listed below.


Ingredient matches for Enalamerck



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalamerck in the following countries:


  • Japan

International Drug Name Search

Pentagin




Pentagin may be available in the countries listed below.


Ingredient matches for Pentagin



Pentazocine

Pentazocine is reported as an ingredient of Pentagin in the following countries:


  • Japan

International Drug Name Search

Rosicon-MF




Rosicon-MF may be available in the countries listed below.


Ingredient matches for Rosicon-MF



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Rosicon-MF in the following countries:


  • Myanmar

Rosiglitazone

Rosiglitazone maleate (a derivative of Rosiglitazone) is reported as an ingredient of Rosicon-MF in the following countries:


  • Myanmar

International Drug Name Search

Wednesday 20 October 2010

Thyrax Duotab




Thyrax Duotab may be available in the countries listed below.


Ingredient matches for Thyrax Duotab



Levothyroxine

Levothyroxine sodium salt (a derivative of Levothyroxine) is reported as an ingredient of Thyrax Duotab in the following countries:


  • Luxembourg

  • Netherlands

International Drug Name Search

Monday 18 October 2010

GenRX Terbinafine




GenRX Terbinafine may be available in the countries listed below.


Ingredient matches for GenRX Terbinafine



Terbinafine

Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of GenRX Terbinafine in the following countries:


  • Australia

International Drug Name Search

Sunday 17 October 2010

Fenemal DLF




Fenemal DLF may be available in the countries listed below.


Ingredient matches for Fenemal DLF



Phenobarbital

Phenobarbital is reported as an ingredient of Fenemal DLF in the following countries:


  • Denmark

International Drug Name Search

Tuesday 12 October 2010

Zopiclon Merck




Zopiclon Merck may be available in the countries listed below.


Ingredient matches for Zopiclon Merck



Eszopiclone

Zopiclone is reported as an ingredient of Zopiclon Merck in the following countries:


  • Netherlands

International Drug Name Search

Sunday 10 October 2010

Ritiométan




Ritiométan may be available in the countries listed below.


Ingredient matches for Ritiométan



Ritiometan

Ritiométan (DCF) is also known as Ritiometan (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday 4 October 2010

Depacon




In the US, Depacon (valproic acid systemic) is a member of the drug class fatty acid derivative anticonvulsants and is used to treat Seizure Prevention and Seizures.

US matches:

  • Depacon

Ingredient matches for Depacon



Valproic Acid

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Depacon in the following countries:


  • United States

International Drug Name Search

Ibuprofeno Klonal




Ibuprofeno Klonal may be available in the countries listed below.


Ingredient matches for Ibuprofeno Klonal



Ibuprofen

Ibuprofen is reported as an ingredient of Ibuprofeno Klonal in the following countries:


  • Argentina

International Drug Name Search

Friday 1 October 2010

Risidon




Risidon may be available in the countries listed below.


Ingredient matches for Risidon



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Risidon in the following countries:


  • Portugal

International Drug Name Search

Saturday 25 September 2010

Rhinigine




Rhinigine may be available in the countries listed below.


Ingredient matches for Rhinigine



Loratadine

Loratadine is reported as an ingredient of Rhinigine in the following countries:


  • South Africa

International Drug Name Search

Monday 20 September 2010

Bilumide




Bilumide may be available in the countries listed below.


Ingredient matches for Bilumide



Bicalutamide

Bicalutamide is reported as an ingredient of Bilumide in the following countries:


  • Greece

International Drug Name Search

Sunday 19 September 2010

Nicotine Polacrilex




Ingredient matches for Nicotine Polacrilex



Nicotine

Nicotine Polacrilex (USAN) is known as Nicotine in the US.

International Drug Name Search

Glossary

USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Virpes




Virpes may be available in the countries listed below.


Ingredient matches for Virpes



Acyclovir

Aciclovir is reported as an ingredient of Virpes in the following countries:


  • Oman

International Drug Name Search

Tuesday 14 September 2010

Nimodilat




Nimodilat may be available in the countries listed below.


Ingredient matches for Nimodilat



Nimodipine

Nimodipine is reported as an ingredient of Nimodilat in the following countries:


  • Argentina

International Drug Name Search

Antibiotrex




Antibiotrex may be available in the countries listed below.


Ingredient matches for Antibiotrex



Erythromycin

Erythromycin is reported as an ingredient of Antibiotrex in the following countries:


  • France

Isotretinoin

Isotretinoin is reported as an ingredient of Antibiotrex in the following countries:


  • France

International Drug Name Search

Monday 13 September 2010

Klaritromycin STADA




Klaritromycin STADA may be available in the countries listed below.


Ingredient matches for Klaritromycin STADA



Clarithromycin

Clarithromycin is reported as an ingredient of Klaritromycin STADA in the following countries:


  • Sweden

International Drug Name Search

Saturday 11 September 2010

Razor




Razor may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Razor



Ivermectin

Ivermectin is reported as an ingredient of Razor in the following countries:


  • Australia

Praziquantel

Praziquantel is reported as an ingredient of Razor in the following countries:


  • Australia

International Drug Name Search

Friday 10 September 2010

Céliprolol Ranbaxy




Céliprolol Ranbaxy may be available in the countries listed below.


Ingredient matches for Céliprolol Ranbaxy



Celiprolol

Celiprolol hydrochloride (a derivative of Celiprolol) is reported as an ingredient of Céliprolol Ranbaxy in the following countries:


  • France

International Drug Name Search

Thursday 9 September 2010

Dulera


Dulera is a brand name of formoterol/mometasone, approved by the FDA in the following formulation(s):


DULERA (formoterol fumarate; mometasone furoate - aerosol, metered; inhalation)



  • Manufacturer: SCHERING

    Approval date: June 22, 2010

    Strength(s): 0.005MG/INH;0.1MG/INH [RLD], 0.005MG/INH;0.2MG/INH [RLD]

Has a generic version of Dulera been approved?


No. There is currently no therapeutically equivalent version of Dulera available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Dulera. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Use of mometasone furoate for treating lower airway passage and lung diseases
    Patent 5,889,015
    Issued: March 30, 1999
    Inventor(s): Sequeira; Joel A. & Cuss; Francis M. & Nolop; Keith B. & Chaudry; Imtiaz A. & Nagabhushan; Nagamani & Patrick; James E. & Cayen; Mitchell
    Assignee(s): Schering Corporation
    The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Patent expiration dates:

    • January 27, 2014
      ✓ 
      Patent use: TREATMENT OF ASTHMA


    • July 27, 2014
      ✓ 
      Pediatric exclusivity




  • Use of mometasone furoate for treating airway passage and lung diseases
    Patent 6,057,307
    Issued: May 2, 2000
    Inventor(s): Sequeira; Joel A. & Cuss; Francis M. & Nolop; Keith B. & Chaudry; Imtiaz A. & Nagabhushan; Nagamani & Patrick; James E. & Cayen; Mitchell
    Assignee(s): Schering Corporation
    The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Patent expiration dates:

    • January 27, 2014
      ✓ 
      Patent use: TREATMENT OF ASTHMA
      ✓ 
      Drug product


    • July 27, 2014
      ✓ 
      Pediatric exclusivity




  • Chlorofluorocarbon-free mometasone furoate aerosol formulations
    Patent 6,068,832
    Issued: May 30, 2000
    Inventor(s): Berry; Julianne & Sequeira; Joel A. & Chaudry; Imtiaz A.
    Assignee(s): Schering Corporation
    The invention relates to suspension aerosol formulations which exhibit stable particle sizes, containing mometasone furoate, about 1 to about 10 weight percent ethanol and 1,1,1,2,3,3,3-Heptafluoropropane as the propellant. A surfactant, such as oleic acid, can also be included. These formulations are suitable for use in metered dose inhalers.
    Patent expiration dates:

    • August 27, 2017
      ✓ 
      Patent use: TREATMENT OF ASTHMA
      ✓ 
      Drug product




  • Use of mometasone furoate for treating airway passage and lung diseases
    Patent 6,677,323
    Issued: January 13, 2004
    Inventor(s): Joel A.; Sequeira & Francis M.; Cuss & Keith B.; Nolop & Imtiaz A.; Chaudry & Nagamani; Nagabhushan & James E.; Patrick & Mitchell; Cayen
    Assignee(s): Schering Corporation
    The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Patent expiration dates:

    • January 27, 2014
      ✓ 
      Patent use: TREATMENT OF ASTHMA




  • Combinations of formoterol and mometasone furoate for asthma
    Patent 7,067,502
    Issued: June 27, 2006
    Inventor(s): Hassan; Ian Francis & Clarke; Jeremy Guy & Danahay; Henry Luke
    Assignee(s): Novartis AG
    A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or a solvate of the salt and (B) mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.
    Patent expiration dates:

    • May 21, 2020
      ✓ 
      Patent use: TREATMENT OF ASTHMA
      ✓ 
      Drug product




  • Combination of formoterol and mometasone furoate for asthma
    Patent 7,566,705
    Issued: July 28, 2009
    Inventor(s): Hassan; Ian F & Clarke; Jeremy G & Danahay; Henry L
    Assignee(s): Novartis AG
    A medicament containing, separately or together, (A) formoterol or a pharmaceutically acceptable salt thereof or a solvate of formoterol or a solvate of the salt and (B) mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease.
    Patent expiration dates:

    • May 8, 2020
      ✓ 
      Patent use: TREATMENT OF ASTHMA
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • June 22, 2013 - NEW COMBINATION

See also...

  • Dulera Consumer Information (Drugs.com)
  • Dulera Inhalation Aerosol Consumer Information (Wolters Kluwer)
  • Dulera Consumer Information (Cerner Multum)
  • Dulera Advanced Consumer Information (Micromedex)
  • Mometasone/Formoterol Inhalation Aerosol Consumer Information (Wolters Kluwer)
  • Formoterol and mometasone Consumer Information (Cerner Multum)
  • Mometasone and formoterol Inhalation Advanced Consumer Information (Micromedex)

Tuesday 7 September 2010

Co-Quinapril Sandoz




Co-Quinapril Sandoz may be available in the countries listed below.


Ingredient matches for Co-Quinapril Sandoz



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Co-Quinapril Sandoz in the following countries:


  • Belgium

Quinapril

Quinapril hydrochloride (a derivative of Quinapril) is reported as an ingredient of Co-Quinapril Sandoz in the following countries:


  • Belgium

International Drug Name Search

Saturday 4 September 2010

Xylocaina Viscosa




Xylocaina Viscosa may be available in the countries listed below.


Ingredient matches for Xylocaina Viscosa



Lidocaine

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Xylocaina Viscosa in the following countries:


  • Argentina

  • Chile

International Drug Name Search

Thursday 2 September 2010

Dermal Necrosis Medications


Topics under Dermal Necrosis

  • Dermal Necrosis, Prophylaxis (10 drugs)

  • Dermal Necrosis, Treatment (1 drug)





Drug List:

Sunday 22 August 2010

Reclide




Reclide may be available in the countries listed below.


Ingredient matches for Reclide



Gliclazide

Gliclazide is reported as an ingredient of Reclide in the following countries:


  • Myanmar

  • Sri Lanka

  • Venezuela

International Drug Name Search

Thursday 19 August 2010

Gen-Salbutamol




Gen-Salbutamol may be available in the countries listed below.


Ingredient matches for Gen-Salbutamol



Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Gen-Salbutamol in the following countries:


  • Canada

International Drug Name Search

Monday 16 August 2010

Ferricure




Ferricure may be available in the countries listed below.


Ingredient matches for Ferricure



Iron Sucrose

Iron Sucrose is reported as an ingredient of Ferricure in the following countries:


  • Belgium

International Drug Name Search

Friday 13 August 2010

Lovastatin Stada




Lovastatin Stada may be available in the countries listed below.


Ingredient matches for Lovastatin Stada



Lovastatin

Lovastatin is reported as an ingredient of Lovastatin Stada in the following countries:


  • Austria

  • Finland

  • Germany

International Drug Name Search

Thursday 12 August 2010

Betnovate-C




Betnovate-C may be available in the countries listed below.


Ingredient matches for Betnovate-C



Betamethasone

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Betnovate-C in the following countries:


  • Greece

  • New Zealand

  • Poland

  • Switzerland

Clioquinol

Clioquinol is reported as an ingredient of Betnovate-C in the following countries:


  • Greece

  • New Zealand

  • Poland

  • Switzerland

International Drug Name Search

Megestron




Megestron may be available in the countries listed below.


Ingredient matches for Megestron



Medroxyprogesterone

Medroxyprogesterone is reported as an ingredient of Megestron in the following countries:


  • Peru

Medroxyprogesterone 17α-acetate (a derivative of Medroxyprogesterone) is reported as an ingredient of Megestron in the following countries:


  • Colombia

  • Ethiopia

  • Ghana

  • Kenya

  • Mexico

  • Netherlands

  • Romania

  • Serbia

  • Tanzania

  • Zimbabwe

International Drug Name Search

Marcaina




Marcaina may be available in the countries listed below.


Ingredient matches for Marcaina



Bupivacaine

Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Marcaina in the following countries:


  • Brazil

  • Italy

  • Portugal

International Drug Name Search

Tuesday 3 August 2010

Monovas




Monovas may be available in the countries listed below.


Ingredient matches for Monovas



Amlodipine

Amlodipine is reported as an ingredient of Monovas in the following countries:


  • Turkey

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Monovas in the following countries:


  • Bosnia & Herzegowina

International Drug Name Search

Nymiko




Nymiko may be available in the countries listed below.


Ingredient matches for Nymiko



Nystatin

Nystatin is reported as an ingredient of Nymiko in the following countries:


  • Indonesia

International Drug Name Search

Friday 23 July 2010

Neurotioct




Neurotioct may be available in the countries listed below.


Ingredient matches for Neurotioct



Thioctic Acid

Thioctic Acid is reported as an ingredient of Neurotioct in the following countries:


  • Argentina

International Drug Name Search

Sunday 18 July 2010

PMS-Clindamycin




PMS-Clindamycin may be available in the countries listed below.


Ingredient matches for PMS-Clindamycin



Clindamycin

Clindamycin hydrochloride (a derivative of Clindamycin) is reported as an ingredient of PMS-Clindamycin in the following countries:


  • Canada

International Drug Name Search

Thursday 15 July 2010

Nufolic




Nufolic may be available in the countries listed below.


Ingredient matches for Nufolic



Folic Acid

Folic Acid is reported as an ingredient of Nufolic in the following countries:


  • Indonesia

International Drug Name Search

Tomit




Tomit may be available in the countries listed below.


Ingredient matches for Tomit



Metoclopramide

Metoclopramide hydrochloride (a derivative of Metoclopramide) is reported as an ingredient of Tomit in the following countries:


  • Indonesia

International Drug Name Search

Zylet




In the US, Zylet (loteprednol/tobramycin ophthalmic) is a member of the drug class ophthalmic steroids with anti-infectives and is used to treat Conjunctivitis - Bacterial, Cyclitis, Iritis, Keratitis and Uveitis.

US matches:

  • Zylet

  • Zylet Drops

Ingredient matches for Zylet



Loteprednol

Loteprednol etabonate (a derivative of Loteprednol) is reported as an ingredient of Zylet in the following countries:


  • United States

Tobramycin

Tobramycin is reported as an ingredient of Zylet in the following countries:


  • United States

International Drug Name Search

Saturday 10 July 2010

Nackless




Nackless may be available in the countries listed below.


Ingredient matches for Nackless



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Nackless in the following countries:


  • Japan

International Drug Name Search

Thursday 8 July 2010

Vepesid




In the US, Vepesid (etoposide systemic) is a member of the drug class mitotic inhibitors and is used to treat Cancer, Hodgkin's Lymphoma, Ovarian Cancer, Small Cell Lung Cancer and Testicular Cancer.

US matches:

  • VePesid

  • Vepesid Oral

UK matches:

  • Vepesid Soft Capsules 50 mg and 100 mg (SPC)

Ingredient matches for Vepesid



Etoposide

Etoposide is reported as an ingredient of Vepesid in the following countries:


  • Argentina

  • Australia

  • Austria

  • Belgium

  • Bosnia & Herzegowina

  • Brazil

  • Colombia

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Estonia

  • Finland

  • Georgia

  • Germany

  • Greece

  • Hong Kong

  • Hungary

  • Ireland

  • Italy

  • Japan

  • Lithuania

  • Luxembourg

  • Mexico

  • Netherlands

  • New Zealand

  • Norway

  • Philippines

  • Poland

  • Portugal

  • Romania

  • Russian Federation

  • Serbia

  • Slovakia

  • Slovenia

  • South Africa

  • Spain

  • Sweden

  • Switzerland

  • Taiwan

  • Thailand

  • Turkey

  • United Kingdom

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday 2 July 2010

Nasdro




Nasdro may be available in the countries listed below.


Ingredient matches for Nasdro



Naphazoline

Naphazoline nitrate (a derivative of Naphazoline) is reported as an ingredient of Nasdro in the following countries:


  • South Africa

Phenylephrine

Phenylephrine hydrochloride (a derivative of Phenylephrine) is reported as an ingredient of Nasdro in the following countries:


  • South Africa

International Drug Name Search

Thursday 1 July 2010

Vitamin-C-Nosik




Vitamin-C-Nosik may be available in the countries listed below.


Ingredient matches for Vitamin-C-Nosik



Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Vitamin-C-Nosik in the following countries:


  • Luxembourg

International Drug Name Search

Sunday 27 June 2010

Ketin




Ketin may be available in the countries listed below.


Ingredient matches for Ketin



Ketotifen

Ketotifen is reported as an ingredient of Ketin in the following countries:


  • Tunisia

International Drug Name Search

Saturday 26 June 2010

Hidrozona




Hidrozona may be available in the countries listed below.


Ingredient matches for Hidrozona



Hydrocortisone

Hydrocortisone is reported as an ingredient of Hidrozona in the following countries:


  • Venezuela

International Drug Name Search

Carnitina




Carnitina may be available in the countries listed below.


Ingredient matches for Carnitina



Carnitine

Carnitina (DCIT) is also known as Carnitine (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday 24 June 2010

Purinéthol




Purinéthol may be available in the countries listed below.


Ingredient matches for Purinéthol



Mercaptopurine

Mercaptopurine monohydrate (a derivative of Mercaptopurine) is reported as an ingredient of Purinéthol in the following countries:


  • France

International Drug Name Search

Saturday 19 June 2010

Gordochrom




Ingredient matches for Gordochrom



Undecylenic Acid

Undecylenic Acid is reported as an ingredient of Gordochrom in the following countries:


  • United States

International Drug Name Search

Wednesday 16 June 2010

Ery




Ery may be available in the countries listed below.


Ingredient matches for Ery



Erythromycin

Erythromycin is reported as an ingredient of Ery in the following countries:


  • Algeria

  • Bangladesh

  • Tunisia

Erythromycin ethylsuccinate (a derivative of Erythromycin) is reported as an ingredient of Ery in the following countries:


  • France

  • Luxembourg

  • Vietnam

Erythromycin propionate (a derivative of Erythromycin) is reported as an ingredient of Ery in the following countries:


  • Algeria

  • Benin

  • Burkina Faso

  • Cameroon

  • Central African Republic

  • Chad

  • Congo

  • Cote D'ivoire

  • France

  • Gabon

  • Guinea

  • Madagascar

  • Mali

  • Mauritania

  • Mauritius

  • Niger

  • Senegal

  • Togo

  • Zaire

International Drug Name Search

Sunday 13 June 2010

Glormin




Glormin may be available in the countries listed below.


Ingredient matches for Glormin



Atenolol

Atenolol is reported as an ingredient of Glormin in the following countries:


  • Bahrain

  • Oman

International Drug Name Search

Tuesday 8 June 2010

Broomhexine HCl Katwijk




Broomhexine HCl Katwijk may be available in the countries listed below.


Ingredient matches for Broomhexine HCl Katwijk



Bromhexine

Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Broomhexine HCl Katwijk in the following countries:


  • Netherlands

International Drug Name Search

Monday 7 June 2010

Biseptol




Biseptol may be available in the countries listed below.


Ingredient matches for Biseptol



Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Biseptol in the following countries:


  • Bulgaria

  • Czech Republic

  • Estonia

  • Georgia

  • Latvia

  • Lithuania

  • Poland

  • Romania

  • Russian Federation

  • Slovakia

Trimethoprim

Trimethoprim is reported as an ingredient of Biseptol in the following countries:


  • Bulgaria

  • Czech Republic

  • Estonia

  • Latvia

  • Lithuania

  • Poland

  • Romania

  • Russian Federation

  • Slovakia

International Drug Name Search

Sunday 6 June 2010

Ketoptic




Ketoptic may be available in the countries listed below.


Ingredient matches for Ketoptic



Ketotifen

Ketotifen fumarate (a derivative of Ketotifen) is reported as an ingredient of Ketoptic in the following countries:


  • Venezuela

International Drug Name Search

Saturday 5 June 2010

Methylmethionine Sulfonium Chloride




Scheme

JAN

CAS registry number (Chemical Abstracts Service)

0001115-84-0

Chemical Formula

C6-H14-Cl-N-O2-S

Molecular Weight

199

Therapeutic Category

Treatment of peptic ulcer

Chemical Names

(S)-(3-Amino-3-carboxypropyl)dimethylsulfonium chloride

Sulfonium, (3-amino-3-carboxypropyl)dimethyl-, chloride, L-

Generic Names

  • Methylmethionine Sulfonium Chloride (OS: JAN)
  • MMSC (IS)
  • Vitamin U (IS)

Brand Names

  • Cabagin-U
    Kowa Souyaku, Japan


  • Thiospen
    Taiyo Pharmaceutical, Japan

International Drug Name Search

Glossary

ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday 2 June 2010

Veralgin




Veralgin may be available in the countries listed below.


Ingredient matches for Veralgin



Dexpanthenol

Dexpanthenol is reported as an ingredient of Veralgin in the following countries:


  • Austria

Tiemonium Methylsulfate

Tiemonium Methylsulfate is reported as an ingredient of Veralgin in the following countries:


  • Bangladesh

International Drug Name Search

Monday 24 May 2010

Bumadizone




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

M01AB07

CAS registry number (Chemical Abstracts Service)

0003583-64-0

Chemical Formula

C19-H22-N2-O3

Molecular Weight

326

Therapeutic Categories

Analgesic, antipyretic and anti-inflammatory agent

Non-steroidal anti-inflammatory drug, NSAID

Chemical Name

Propanedioic acid, butyl-, mono(1,2-diphenylhydrazide)

Foreign Names

  • Bumadizonum (Latin)
  • Bumadizon (German)
  • Bumadizone (French)
  • Bumadizona (Spanish)

Generic Names

  • Bumadizone (OS: DCIT, DCF)
  • B 64114 (IS: Byk Gulden)

Brand Name

  • Desflam
    Merck, Mexico

International Drug Name Search

Glossary

DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday 22 May 2010

Novaminsulfon-ratiopharm




Novaminsulfon-ratiopharm may be available in the countries listed below.


Ingredient matches for Novaminsulfon-ratiopharm



Metamizole

Metamizole sodium monohydrate (a derivative of Metamizole) is reported as an ingredient of Novaminsulfon-ratiopharm in the following countries:


  • Germany

International Drug Name Search

Thursday 20 May 2010

Ezetimibe




In the US, Ezetimibe (ezetimibe systemic) is a member of the drug class cholesterol absorption inhibitors and is used to treat High Cholesterol, High Cholesterol - Familial Heterozygous and Sitosterolemia.

US matches:

  • Ezetimibe

  • Ezetimibe/Simvastatin

  • Ezetimibe and simvastatin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C10AX09

CAS registry number (Chemical Abstracts Service)

0163222-33-1

Chemical Formula

C24-H21-F2-N-O3

Molecular Weight

409

Therapeutic Category

Antilipemic agent, cholesterol absorption inhibitor

Chemical Names

[3R,4S]-1-[p-Fluorophenyl]-3-[[3S]-3-[p-fluorophenyl]-3-hydroxypropyl]-4-[p-hydroxyphenyl]-2-azetidinone (WHO)

2-Azetidinone, 1-[4-fluorophenyl]-3-[3-[4-fluorophenyl]-3-hydroxypropyl]-4-[4-hydroxyphenyl]-, [3R-[3[S*],4]]- (USAN)

Foreign Names

  • Ezetimibum (Latin)
  • Ezetimib (German)
  • Ezetimibe (French)
  • Ezetimiba (Spanish)

Generic Name

  • Ezetimibe (OS: USAN, BAN)

Brand Names

  • Acotral
    Phoenix, Argentina


  • Alin
    Lazar, Argentina


  • Alipas
    Laboratorios, Argentina


  • Atorvik-EZ (Ezetimibe and Atorvastatin)
    Anvik, India


  • Avascare-EZ (Ezetimibe and Calcium Atorvastatin)
    Q-Check, India


  • Cerclerol
    Beta, Argentina


  • Coracil
    Gador, Argentina


  • Corexel
    Novartis, Argentina


  • Ezator (Ezetimibe and Atorvastatin)
    Farmindustria, Peru


  • Ezentia
    Sun, Myanmar


  • Ezeta
    Beximco, Bangladesh


  • Ezetib
    Unichem, India


  • Ezetim
    Incepta, Bangladesh


  • Ezetimibe-MSD
    Merck Sharp & Dohme, Germany; Merck Sharp & Dohme, Luxembourg


  • Ezetrol
    Combiphar, Netherlands; Delphi, Netherlands; Dr. Fisher, Netherlands; Essex, Germany; Euro, Netherlands; Medcor, Netherlands; Merck, Czech Republic; Merck Frosst, Canada; Merck Sharp & Dhome, Oman; Merck Sharp & Dohme, Netherlands Antilles; Merck Sharp & Dohme, Argentina; Merck Sharp & Dohme, Austria; Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Aruba; Merck Sharp & Dohme, Bosnia & Herzegowina; Merck Sharp & Dohme, Barbados; Merck Sharp & Dohme, Belgium; Merck Sharp & Dohme, Bahrain; Merck Sharp & Dohme, Bahamas; Merck Sharp & Dohme, Belize; Merck Sharp & Dohme, Chile; Merck Sharp & Dohme, China; Merck Sharp & Dohme, Colombia; Merck Sharp & Dohme, Germany; Merck Sharp & Dohme, Ecuador; Merck Sharp & Dohme, Estonia; Merck Sharp & Dohme, Spain; Merck Sharp & Dohme, France; Merck Sharp & Dohme, Hong Kong; Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, Hungary; Merck Sharp & Dohme, Iceland; Merck Sharp & Dohme, Italy; Merck Sharp & Dohme, Jamaica; Merck Sharp & Dohme, Cayman Islands; Merck Sharp & Dohme, Lithuania; Merck Sharp & Dohme, Luxembourg; Merck Sharp & Dohme, Latvia; Merck Sharp & Dohme, Malta; Merck Sharp & Dohme, Mexico; Merck Sharp & Dohme, Malaysia; Merck Sharp & Dohme, Netherlands; Merck Sharp & Dohme, New Zealand; Merck Sharp & Dohme, Portugal; Merck Sharp & Dohme, Romania; Merck Sharp & Dohme, Serbia; Merck Sharp & Dohme, Russian Federation; Merck Sharp & Dohme, Sweden; Merck Sharp & Dohme, Singapore; Merck Sharp & Dohme, Slovenia; Merck Sharp & Dohme, Slovakia; Merck Sharp & Dohme, Turkey; Merck Sharp & Dohme, Trinidad & Tobago; Merck Sharp & Dohme, Taiwan; Merck Sharp & Dohme, Venezuela; Merck Sharp & Dohme, South Africa; Merck Sharp & Dome, Dominican Republic; MSD, Switzerland; MSD, Denmark; MSD, Finland; MSD, Georgia; MSD, Peru; MSD-SP, United Kingdom; MSD-SP, Ireland; MSD-SP, Norway; Schering-Plough, Belgium; Schering-Plough, Indonesia; Schering-Plough, Malaysia; Schering-Plough, Philippines; Schering-Plough, Russian Federation; Schering-Plough, Sweden; Schering-Plough, Singapore; Schering-Plough, Thailand; Vianex / BIANEΞ, Greece


  • Ezitoget
    Getz Pharma, Vietnam


  • Goltor (Ezetimibe and Simvastatin)
    Merck Sharp & Dohme, Germany


  • InductOs
    Wyeth, Slovenia


  • Inegy (Ezetimibe and Simvastatin)
    Combiphar, Netherlands; Dr. Fisher, Netherlands; Eureco, Netherlands; Euro, Netherlands; Medcor, Netherlands; Merck Sharp & Dohme, Austria; Merck Sharp & Dohme, Belgium; Merck Sharp & Dohme, Bulgaria; Merck Sharp & Dohme, Bulgaria; Merck Sharp & Dohme, Bahrain; Merck Sharp & Dohme, Germany; Merck Sharp & Dohme, France; Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, Hungary; Merck Sharp & Dohme, Ireland; Merck Sharp & Dohme, Italy; Merck Sharp & Dohme, Malta; Merck Sharp & Dohme, Netherlands; Merck Sharp & Dohme, Sweden; MSD, Switzerland; MSD, Denmark; MSD-SP, United Kingdom; MSD-SP, Norway; Schering-Plough, Hungary; Vianex / BIANEΞ, Greece


  • Ixacor
    Roemmers, Argentina


  • Nalecol
    Casasco, Argentina


  • Sinterol
    Klonal, Argentina


  • Trilip
    Elea, Argentina


  • Vadel
    Ivax, Argentina


  • Viemm
    Merck Sharp & Dohme, Germany


  • Visvas-EZ (Ezetimibe and Atorvastatin)
    Minova, India


  • Vytorin (Ezetimibe and Simvastatin)
    Merck / Schering-Plough, United States; Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Germany; Merck Sharp & Dohme, New Zealand; Merck Sharp & Dohme, Singapore; Schering-Plough, Indonesia; Schering-Plough, Thailand


  • Zeklen (Ezetimibe and Simvastatin)
    Merck Sharp & Dohme, Germany


  • Zetia
    Merck, United States; Merck / Schering-Plough, United States; Plough, Colombia; Schering, United States; Schering-Plough, Argentina; Schering-Plough, Brazil; Schering-Plough, Costa Rica; Schering-Plough, Dominican Republic; Schering-Plough, Guatemala; Schering-Plough, Japan; Schering-Plough, Nicaragua; Schering-Plough, Panama; Schering-Plough, Peru; Schering-Plough, El Salvador; Schering-Plough, Venezuela


  • Zient
    Essex, Chile; Essex, Ecuador; Merck Sharp & Dohme, Germany; Schering-Plough, Mexico; Schering-Plough, Venezuela

International Drug Name Search

Glossary

BANBritish Approved Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday 16 May 2010

Lomerizine Hydrochloride




Lomerizine Hydrochloride may be available in the countries listed below.


Ingredient matches for Lomerizine Hydrochloride



Lomerizine

Lomerizine Hydrochloride (JAN) is also known as Lomerizine (Rec.INN)

International Drug Name Search

Glossary

JANJapanese Accepted Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday 14 May 2010

Roiplon




Roiplon may be available in the countries listed below.


Ingredient matches for Roiplon



Etofenamate

Etofenamate is reported as an ingredient of Roiplon in the following countries:


  • Greece

International Drug Name Search

Wednesday 12 May 2010

Acidum Aminocapronicum 5%




Acidum Aminocapronicum 5% may be available in the countries listed below.


Ingredient matches for Acidum Aminocapronicum 5%



Aminocaproic Acid

Aminocaproic Acid is reported as an ingredient of Acidum Aminocapronicum 5% in the following countries:


  • Georgia

International Drug Name Search

Benzoyl Peroxide/Erythromycin Gel


Pronunciation: BEN-zoyl per-OX-ide/eh-RITH-row-MY-sin
Generic Name: Benzoyl Peroxide/Erythromycin
Brand Name: Examples include Benzamycin and Benzamycin Pak


Benzoyl Peroxide/Erythromycin Gel is used for:

Treating severe acne. It may be used with other acne medications.


Benzoyl Peroxide/Erythromycin Gel is a combination macrolide antibiotic and keratolytic (drying) agent with antibacterial actions. The effectiveness of benzoyl peroxide appears to be due to its antibacterial, peeling (keratolytic), and drying actions. How topical erythromycin treats acne is not fully known. It is thought that the improvement in acne is due to the ability of topically applied erythromycin to slow the growth on the skin of bacteria that cause the acne.


Do NOT use Benzoyl Peroxide/Erythromycin Gel if:


  • you are allergic to any ingredient in Benzoyl Peroxide/Erythromycin Gel

Contact your doctor or health care provider right away if any of these apply to you.



Before using Benzoyl Peroxide/Erythromycin Gel:


Some medical conditions may interact with Benzoyl Peroxide/Erythromycin Gel. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have liver problems or a blood disorder

Some MEDICINES MAY INTERACT with Benzoyl Peroxide/Erythromycin Gel. Because little, if any, of Benzoyl Peroxide/Erythromycin Gel is absorbed into the blood, the risk of it interacting with another medicine is low.


Ask your health care provider if Benzoyl Peroxide/Erythromycin Gel may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Benzoyl Peroxide/Erythromycin Gel:


Use Benzoyl Peroxide/Erythromycin Gel as directed by your doctor. Check the label on the medicine for exact dosing instructions. Check the label on the medicine for exact dosing instructions.


  • Before using Benzoyl Peroxide/Erythromycin Gel, thoroughly wash, rinse with warm water, and gently dry your skin.

  • Apply and rub in a thin film of medicine to the affected skin and surrounding areas using the fingertips or applicator provided.

  • Wash your hands after using Benzoyl Peroxide/Erythromycin Gel.

  • Benzoyl Peroxide/Erythromycin Gel works best if used at the same time(s) each day.

  • If you miss a dose of Benzoyl Peroxide/Erythromycin Gel, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Benzoyl Peroxide/Erythromycin Gel.



Important safety information:


  • Use on the skin only. Avoid getting Benzoyl Peroxide/Erythromycin Gel in your eyes, on the inside of your nose or mouth, on highly inflamed or damaged skin, or on your lips. If you get Benzoyl Peroxide/Erythromycin Gel in your eyes, immediately wash them out with cool tap water.

  • Avoid applying Benzoyl Peroxide/Erythromycin Gel to raw or irritated skin, including sunburns and open wounds.

  • If applying another medicine for acne, wait at least 1 hour before applying the second medicine.

  • Once you begin using Benzoyl Peroxide/Erythromycin Gel, it may take 3 to 8 weeks before you begin to see improvement. If your symptoms do not improve by 12 weeks or if they become worse, check with your doctor.

  • While you are using Benzoyl Peroxide/Erythromycin Gel, use only water-based cosmetics.

  • Talk with your doctor before you use any other medicines or special cleansers on your skin.

  • Benzoyl Peroxide/Erythromycin Gel may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Benzoyl Peroxide/Erythromycin Gel. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.

  • Benzoyl Peroxide/Erythromycin Gel may cause bleaching. Avoid contact with hair, fabrics, or carpeting.

  • Benzoyl Peroxide/Erythromycin Gel should be used with extreme caution in CHILDREN younger than 12 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Benzoyl Peroxide/Erythromycin Gel while you are pregnant. It is not known if Benzoyl Peroxide/Erythromycin Gel is found in breast milk. If you are or will be breast-feeding while you use Benzoyl Peroxide/Erythromycin Gel, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Benzoyl Peroxide/Erythromycin Gel:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Dryness; feeling of warmth; hives; irritation; itching; peeling; redness; stinging; swelling of the skin.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; dizziness; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); excessive burning, itching, redness, or tenderness of the skin; extreme dryness; severe irritation; sloughing of the skin; swelling of the treated areas.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Benzoyl Peroxide/Erythromycin side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include excessive scaling, flushing, redness, and swelling of the skin.


Proper storage of Benzoyl Peroxide/Erythromycin Gel:

Storage of Pak: Store Benzoyl Peroxide/Erythromycin Gel at room temperature at 68 to 77 degrees F (20 to 25 degrees C). Store in a tightly closed container after it has been mixed. Do not freeze. Discard unused medicine after 3 months. Keep Benzoyl Peroxide/Erythromycin Gel out of the reach of children and away from pets.


Storage of Jar: Store Benzoyl Peroxide/Erythromycin Gel in the refrigerator at 36 to 46 degrees F (2 to 8 degrees C). Store in a tightly closed container after it has been mixed. Do not freeze. Discard unused medicine after 3 months. Keep Benzoyl Peroxide/Erythromycin Gel out of the reach of children and away from pets.


General information:


  • If you have any questions about Benzoyl Peroxide/Erythromycin Gel, please talk with your doctor, pharmacist, or other health care provider.

  • Benzoyl Peroxide/Erythromycin Gel is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Benzoyl Peroxide/Erythromycin Gel. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Benzoyl Peroxide/Erythromycin resources


  • Benzoyl Peroxide/Erythromycin Side Effects (in more detail)
  • Benzoyl Peroxide/Erythromycin Dosage
  • Benzoyl Peroxide/Erythromycin Use in Pregnancy & Breastfeeding
  • Benzoyl Peroxide/Erythromycin Drug Interactions
  • Benzoyl Peroxide/Erythromycin Support Group
  • 3 Reviews for Benzoyl Peroxide/Erythromycin - Add your own review/rating


Compare Benzoyl Peroxide/Erythromycin with other medications


  • Acne

Sunday 9 May 2010

Bclotis




Bclotis may be available in the countries listed below.


Ingredient matches for Bclotis



Beclometasone

Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Bclotis in the following countries:


  • Myanmar

International Drug Name Search

Friday 7 May 2010

Rociverine




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A03AA06

CAS registry number (Chemical Abstracts Service)

0053716-44-2

Chemical Formula

C20-H37-N-O3

Molecular Weight

339

Therapeutic Category

Antispasmodic agent

Chemical Name

[1,1'-Bicyclohexyl]-2-carboxylic acid, 1-hydroxy-, 2-(diethylamino)-1-methylethyl ester

Foreign Names

  • Rociverinum (Latin)
  • Rociverin (German)
  • Rocivérine (French)
  • Rociverina (Spanish)

Generic Names

  • Rociverina (OS: DCIT)
  • LG 30158 (IS)

Brand Names

  • Rilaten
    Berlin-Chemie, China; Biotoscana, Colombia; Guidotti, Italy; Menarini, Dominican Republic; Menarini, Guatemala; Menarini, Honduras; Menarini, Nicaragua; Menarini, Panama; Menarini, El Salvador

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.